ICU Medical, Inc. (ICUI)
USD 133.97
(-5.82%)
USD 133.97
(-5.82%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 4.37 Billion USD | -3.04% |
| 2022 | 4.51 Billion USD | 140.1% |
| 2021 | 1.88 Billion USD | 6.64% |
| 2020 | 1.76 Billion USD | 4.21% |
| 2019 | 1.69 Billion USD | 6.75% |
| 2018 | 1.58 Billion USD | 5.91% |
| 2017 | 1.49 Billion USD | 112.43% |
| 2016 | 704.68 Million USD | 12.42% |
| 2015 | 626.82 Million USD | 15.84% |
| 2014 | 541.1 Million USD | 8.3% |
| 2013 | 499.64 Million USD | 16.6% |
| 2012 | 428.51 Million USD | 17.82% |
| 2011 | 363.69 Million USD | 16.48% |
| 2010 | 312.22 Million USD | 0.99% |
| 2009 | 309.15 Million USD | 9.07% |
| 2008 | 283.43 Million USD | 16.83% |
| 2007 | 242.59 Million USD | -0.68% |
| 2006 | 244.24 Million USD | 19.42% |
| 2005 | 204.53 Million USD | 24.14% |
| 2004 | 164.76 Million USD | 0.29% |
| 2003 | 164.28 Million USD | 4.62% |
| 2002 | 157.03 Million USD | 33.82% |
| 2001 | 117.34 Million USD | 26.36% |
| 2000 | 92.86 Million USD | 23.16% |
| 1999 | 75.4 Million USD | 20.83% |
| 1998 | 62.4 Million USD | 21.88% |
| 1997 | 51.2 Million USD | 3.23% |
| 1996 | 49.6 Million USD | 3.55% |
| 1995 | 47.9 Million USD | 82.13% |
| 1994 | 26.3 Million USD | 11.44% |
| 1993 | 23.6 Million USD | 24.21% |
| 1992 | 19 Million USD | 341.86% |
| 1991 | 4.3 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 4.28 Billion USD | -2.06% |
| 2024 Q2 | 4.28 Billion USD | -0.04% |
| 2023 FY | 4.37 Billion USD | -3.04% |
| 2023 Q4 | 4.37 Billion USD | 0.04% |
| 2023 Q3 | 4.37 Billion USD | -1.93% |
| 2023 Q2 | 4.46 Billion USD | -0.17% |
| 2023 Q1 | 4.47 Billion USD | -1.0% |
| 2022 Q4 | 4.51 Billion USD | 1.46% |
| 2022 Q3 | 4.45 Billion USD | -3.04% |
| 2022 Q1 | 4.74 Billion USD | 152.39% |
| 2022 FY | 4.51 Billion USD | 140.1% |
| 2022 Q2 | 4.58 Billion USD | -3.3% |
| 2021 FY | 1.88 Billion USD | 6.64% |
| 2021 Q2 | 1.8 Billion USD | 2.13% |
| 2021 Q3 | 1.83 Billion USD | 2.03% |
| 2021 Q4 | 1.88 Billion USD | 2.25% |
| 2021 Q1 | 1.76 Billion USD | 0.09% |
| 2020 Q3 | 1.72 Billion USD | -6.97% |
| 2020 Q1 | 1.81 Billion USD | 7.36% |
| 2020 Q2 | 1.85 Billion USD | 2.32% |
| 2020 FY | 1.76 Billion USD | 4.21% |
| 2020 Q4 | 1.76 Billion USD | 1.97% |
| 2019 Q3 | 1.63 Billion USD | 0.92% |
| 2019 Q4 | 1.69 Billion USD | 3.33% |
| 2019 Q1 | 1.61 Billion USD | 1.76% |
| 2019 Q2 | 1.62 Billion USD | 0.6% |
| 2019 FY | 1.69 Billion USD | 6.75% |
| 2018 FY | 1.58 Billion USD | 5.91% |
| 2018 Q1 | 1.49 Billion USD | -0.28% |
| 2018 Q3 | 1.54 Billion USD | 1.23% |
| 2018 Q2 | 1.52 Billion USD | 2.25% |
| 2018 Q4 | 1.58 Billion USD | 2.6% |
| 2017 Q3 | 1.52 Billion USD | 2.4% |
| 2017 Q2 | 1.48 Billion USD | 0.97% |
| 2017 FY | 1.49 Billion USD | 112.43% |
| 2017 Q4 | 1.49 Billion USD | -1.71% |
| 2017 Q1 | 1.47 Billion USD | 109.03% |
| 2016 Q4 | 704.68 Million USD | 2.32% |
| 2016 Q3 | 688.69 Million USD | 3.82% |
| 2016 FY | 704.68 Million USD | 12.42% |
| 2016 Q1 | 635.95 Million USD | 1.46% |
| 2016 Q2 | 663.37 Million USD | 4.31% |
| 2015 Q4 | 626.82 Million USD | 2.72% |
| 2015 Q1 | 554.34 Million USD | 2.45% |
| 2015 Q2 | 570.23 Million USD | 2.87% |
| 2015 FY | 626.82 Million USD | 15.84% |
| 2015 Q3 | 610.22 Million USD | 7.01% |
| 2014 FY | 541.1 Million USD | 8.3% |
| 2014 Q4 | 541.1 Million USD | 2.54% |
| 2014 Q3 | 527.71 Million USD | 1.58% |
| 2014 Q1 | 506.43 Million USD | 1.36% |
| 2014 Q2 | 519.51 Million USD | 2.58% |
| 2013 Q3 | 468.68 Million USD | 3.79% |
| 2013 Q2 | 451.56 Million USD | 3.12% |
| 2013 Q1 | 437.88 Million USD | 2.19% |
| 2013 Q4 | 499.64 Million USD | 6.61% |
| 2013 FY | 499.64 Million USD | 16.6% |
| 2012 FY | 428.51 Million USD | 17.82% |
| 2012 Q4 | 428.51 Million USD | 3.78% |
| 2012 Q3 | 412.9 Million USD | 5.17% |
| 2012 Q2 | 392.59 Million USD | 4.28% |
| 2012 Q1 | 376.48 Million USD | 4.26% |
| 2011 Q4 | 361.11 Million USD | 5.13% |
| 2011 FY | 363.69 Million USD | 16.48% |
| 2011 Q1 | 329.19 Million USD | 5.43% |
| 2011 Q2 | 346.32 Million USD | 5.2% |
| 2011 Q3 | 343.5 Million USD | -0.81% |
| 2010 Q4 | 312.22 Million USD | 3.93% |
| 2010 Q3 | 300.42 Million USD | 4.8% |
| 2010 Q2 | 286.67 Million USD | -0.08% |
| 2010 Q1 | 286.9 Million USD | -7.2% |
| 2010 FY | 312.22 Million USD | 0.99% |
| 2009 Q4 | 309.15 Million USD | -0.42% |
| 2009 Q3 | 310.44 Million USD | 3.81% |
| 2009 FY | 309.15 Million USD | 9.07% |
| 2009 Q2 | 299.06 Million USD | 1.72% |
| 2009 Q1 | 294.01 Million USD | 3.73% |
| 2008 Q3 | 269.71 Million USD | 3.65% |
| 2008 Q2 | 260.21 Million USD | 5.35% |
| 2008 Q4 | 283.43 Million USD | 5.09% |
| 2008 FY | 283.43 Million USD | 16.83% |
| 2008 Q1 | 247 Million USD | 1.82% |
| 2007 Q2 | 256.95 Million USD | 3.04% |
| 2007 Q4 | 242.59 Million USD | -1.83% |
| 2007 FY | 242.59 Million USD | -0.68% |
| 2007 Q1 | 249.38 Million USD | 2.1% |
| 2007 Q3 | 247.11 Million USD | -3.83% |
| 2006 FY | 244.24 Million USD | 19.42% |
| 2006 Q4 | 244.24 Million USD | 3.29% |
| 2006 Q1 | 214.99 Million USD | 5.11% |
| 2006 Q2 | 227.89 Million USD | 6.0% |
| 2006 Q3 | 236.47 Million USD | 3.76% |
| 2005 Q1 | 173.3 Million USD | 5.18% |
| 2005 Q3 | 192.09 Million USD | 3.36% |
| 2005 Q4 | 204.53 Million USD | 6.48% |
| 2005 FY | 204.53 Million USD | 24.14% |
| 2005 Q2 | 185.84 Million USD | 7.24% |
| 2004 FY | 164.76 Million USD | 0.29% |
| 2004 Q4 | 164.76 Million USD | -1.38% |
| 2004 Q3 | 167.07 Million USD | -5.46% |
| 2004 Q2 | 176.72 Million USD | 4.54% |
| 2004 Q1 | 169.04 Million USD | 2.89% |
| 2003 Q1 | 156.74 Million USD | -0.18% |
| 2003 Q4 | 164.28 Million USD | 5.28% |
| 2003 FY | 164.28 Million USD | 4.62% |
| 2003 Q3 | 156.05 Million USD | -0.59% |
| 2003 Q2 | 156.98 Million USD | 0.15% |
| 2002 FY | 157.03 Million USD | 33.82% |
| 2002 Q4 | 157.03 Million USD | 7.66% |
| 2002 Q3 | 145.85 Million USD | 4.14% |
| 2002 Q2 | 140.05 Million USD | 5.43% |
| 2002 Q1 | 132.84 Million USD | 13.21% |
| 2001 Q1 | 97.22 Million USD | 4.7% |
| 2001 Q4 | 117.34 Million USD | 7.7% |
| 2001 FY | 117.34 Million USD | 26.36% |
| 2001 Q3 | 108.95 Million USD | 5.69% |
| 2001 Q2 | 103.09 Million USD | 6.04% |
| 2000 FY | 92.86 Million USD | 23.16% |
| 2000 Q4 | 92.86 Million USD | 8.56% |
| 2000 Q3 | 85.53 Million USD | 2.1% |
| 2000 Q2 | 83.78 Million USD | 4.02% |
| 2000 Q1 | 80.54 Million USD | 6.82% |
| 1999 Q4 | 75.4 Million USD | 5.16% |
| 1999 Q1 | 67.1 Million USD | 7.53% |
| 1999 Q3 | 71.7 Million USD | 2.28% |
| 1999 FY | 75.4 Million USD | 20.83% |
| 1999 Q2 | 70.1 Million USD | 4.47% |
| 1998 Q3 | 60.2 Million USD | 2.56% |
| 1998 FY | 62.4 Million USD | 21.88% |
| 1998 Q1 | 55 Million USD | 7.42% |
| 1998 Q2 | 58.7 Million USD | 6.73% |
| 1998 Q4 | 62.4 Million USD | 3.65% |
| 1997 Q3 | 48.3 Million USD | 2.55% |
| 1997 Q1 | 48.9 Million USD | -1.41% |
| 1997 Q4 | 51.2 Million USD | 6.0% |
| 1997 Q2 | 47.1 Million USD | -3.68% |
| 1997 FY | 51.2 Million USD | 3.23% |
| 1996 Q1 | 49.7 Million USD | 3.76% |
| 1996 Q2 | 52 Million USD | 4.63% |
| 1996 Q3 | 52.9 Million USD | 1.73% |
| 1996 FY | 49.6 Million USD | 3.55% |
| 1996 Q4 | 49.6 Million USD | -6.24% |
| 1995 Q2 | 28.9 Million USD | 4.71% |
| 1995 Q1 | 27.6 Million USD | 4.94% |
| 1995 FY | 47.9 Million USD | 82.13% |
| 1995 Q4 | 47.9 Million USD | 4.81% |
| 1995 Q3 | 45.7 Million USD | 58.13% |
| 1994 Q2 | 25.4 Million USD | 2.01% |
| 1994 FY | 26.3 Million USD | 11.44% |
| 1994 Q1 | 24.9 Million USD | 5.51% |
| 1994 Q3 | 26.2 Million USD | 3.15% |
| 1994 Q4 | 26.3 Million USD | 0.38% |
| 1993 Q1 | 20.8 Million USD | 9.47% |
| 1993 Q2 | 21.1 Million USD | 1.44% |
| 1993 Q3 | 21.5 Million USD | 1.9% |
| 1993 Q4 | 23.6 Million USD | 9.77% |
| 1993 FY | 23.6 Million USD | 24.21% |
| 1992 FY | 19 Million USD | 341.86% |
| 1992 Q1 | 4.3 Million USD | 0.0% |
| 1992 Q4 | 19 Million USD | 4.4% |
| 1992 Q2 | 16.9 Million USD | 293.02% |
| 1992 Q3 | 18.2 Million USD | 7.69% |
| 1991 Q4 | 4.3 Million USD | 0.0% |
| 1991 FY | 4.3 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 180.36 Million USD | -2327.49% |
| AngioDynamics, Inc. | 317.67 Million USD | -1278.294% |
| AtriCure, Inc. | 613.93 Million USD | -613.18% |
| Avinger, Inc. | 13.77 Million USD | -31696.943% |
| Azenta, Inc. | 2.88 Billion USD | -51.728% |
| BioLife Solutions, Inc. | 412.71 Million USD | -960.889% |
| The Cooper Companies, Inc. | 11.65 Billion USD | 62.446% |
| Daxor Corporation | 34.86 Million USD | -12456.773% |
| Ekso Bionics Holdings, Inc. | 28.91 Million USD | -15040.878% |
| Femasys Inc. | 27.75 Million USD | -15674.847% |
| GlucoTrack, Inc. | 4.9 Million USD | -89164.811% |
| Harvard Bioscience, Inc. | 137.36 Million USD | -3087.426% |
| Hologic, Inc. | 9.15 Billion USD | 52.18% |
| Intuitive Surgical, Inc. | 15.44 Billion USD | 71.645% |
| KORU Medical Systems, Inc. | 28.46 Million USD | -15284.011% |
| LeMaitre Vascular, Inc. | 346.77 Million USD | -1162.606% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -70306.923% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -70306.923% |
| Masimo Corporation | 3.04 Billion USD | -43.957% |
| Microbot Medical Inc. | 8.32 Million USD | -52481.23% |
| Meihua International Medical Technologies Co., Ltd. | 171.91 Million USD | -2446.859% |
| Merit Medical Systems, Inc. | 2.32 Billion USD | -88.3% |
| Nephros, Inc. | 11.86 Million USD | -36814.586% |
| NovoCure Limited | 1.14 Billion USD | -282.02% |
| NEXGEL, Inc. | 9.95 Million USD | -43882.31% |
| NEXGEL, Inc. | 9.95 Million USD | -43882.31% |
| Singular Genomics Systems, Inc. | 265.46 Million USD | -1549.335% |
| OraSure Technologies, Inc. | 482.84 Million USD | -806.8% |
| Pro-Dex, Inc. | 54.21 Million USD | -7976.811% |
| Pulse Biosciences, Inc. | 60.8 Million USD | -7100.906% |
| Predictive Oncology Inc. | 14.41 Million USD | -30269.448% |
| Precision Optics Corporation, Inc. | 16.91 Million USD | -25788.661% |
| QuidelOrtho Corporation | 8.56 Billion USD | 48.869% |
| Repligen Corporation | 2.82 Billion USD | -55.021% |
| Sanara MedTech Inc. | 73.87 Million USD | -5827.13% |
| STAAR Surgical Company | 488.69 Million USD | -795.951% |
| Sharps Technology, Inc. | 11.78 Million USD | -37039.193% |
| Utah Medical Products, Inc. | 135.45 Million USD | -3132.322% |
| DENTSPLY SIRONA Inc. | 7.37 Billion USD | 40.591% |
| Jin Medical International Ltd. | 32.9 Million USD | -13206.93% |